Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Merck & Co Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Merck & Co Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Merck & Co Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Merck & Co Inc, Medical Equipment, Deal Details 18
Venture Financing 18
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
MedCPU Raises USD9.3 Million in Series B Financing 35
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 36
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 37
WellDoc Raises US$15.7 Million In Venture Financing 38
ClearData Networks Raises US$14 Million In Series B Financing 39
GenomeDx Biosciences Raises Funds Through Series B Financing 40
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 41
Aviir Raises US$20 Million In Venture Financing 43
eHealth Technologies Raises US$6 Million In Series D Financing 45
Remedy Informatics Raises US$6 Million In Venture Financing 46
Healthsense Raises US$7 Million In Series D Financing 47
Liaison Technologies Raises US$30 Million In Venture Financing 48
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 49
Aviir Secures US$10 Million In Venture Financing 50
Daktari Diagnostics Secures US$5 Million In Venture Financing 51
HTG Molecular USD0.5 Million in Second Tranche of Series D Financing 52
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 53
HTG Molecular Raises USD15.7 Million in First Tranche of Series D Financing 54
Private Equity 55
Merck Global Health Acquires Physicians Interactive From Perseus 55
Partnerships 56
Cerveau Technologies Enters into Licensing Agreement with Merck 56
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 57
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 58
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 59
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 60
OpGen Enters into Research Agreement with Merck 61
Takeda Pharma Enters into Agreement with Koneksa Health 62
Merck Enters into Co-Development Agreement with Amoy Diagnostics 63
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 64
Merck to Enter into Co-Development Agreement with Biocartis 65
Daktari Diagnostics Enters into Agreement with Merck 66
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 67
Dako Enters into Agreement with Merck for Companion Diagnostic Test 68
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 69
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 70
Merck Enters Into Co-Development Agreement With Geisinger Health System 71
Ezose Sciences Enters Into Co-Development Agreement With Merck 72
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck 73
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 74
Equity Offering 75
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 75
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 77
Debt Offering 78
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 78
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 79
Acquisition 80
OpGen Acquires AdvanDx 80
Physicians Interactive Acquires Tomorrow Networks 81
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 82
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 84
Merck & Co Inc – Key Competitors 85
Merck & Co Inc – Key Employees 86
Merck & Co Inc – Locations And Subsidiaries 88
Head Office 88
Other Locations & Subsidiaries 88
Joint Venture 111
Recent Developments 112
Strategy And Business Planning 112
Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 112
Financial Announcements 113
Oct 27, 2017: Merck Announces Third-Quarter 2017 Financial Results 113
Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 116
May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 119
Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 121
Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 123
May 05, 2016: Merck Announces First-Quarter 2016 Financial Results 126
Feb 03, 2016: Merck Announces Fourth-Quarter and Full-Year 2015 Financial Results 128
Corporate Communications 131
Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 131
Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 132
Mar 07, 2016: Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division; Will Succeed Willie A. Deese Who Will Retire 133
Legal and Regulatory 134
Jan 15, 2016: Merck Sues Merck for Improper Use of “Merck” 134
Government and Public Interest 135
Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 135
Product News 136
Sep 27, 2016: IDH and CIC Mutations Provide Prognostic Information for Grade II and III Gliomas 136
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released 137
Apr 14, 2016: Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies 138
Other Significant Developments 139
Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 139
Jun 08, 2016: Merck Expands its Investment Fund Merck Ventures 140
Appendix 141
Methodology 141
About GlobalData 141
Contact Us 141
Disclaimer 141
Merck & Co Inc, Medical Equipment, Key Facts, 2016 2
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Merck & Co Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Merck & Co Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Merck & Co Inc, Deals By Market, 2011 to YTD 2017 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
MedCPU Raises USD9.3 Million in Series B Financing 35
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 36
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 37
WellDoc Raises US$15.7 Million In Venture Financing 38
ClearData Networks Raises US$14 Million In Series B Financing 39
GenomeDx Biosciences Raises Funds Through Series B Financing 40
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 41
Aviir Raises US$20 Million In Venture Financing 43
eHealth Technologies Raises US$6 Million In Series D Financing 45
Remedy Informatics Raises US$6 Million In Venture Financing 46
Healthsense Raises US$7 Million In Series D Financing 47
Liaison Technologies Raises US$30 Million In Venture Financing 48
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 49
Aviir Secures US$10 Million In Venture Financing 50
Daktari Diagnostics Secures US$5 Million In Venture Financing 51
HTG Molecular USD0.5 Million in Second Tranche of Series D Financing 52
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round 53
HTG Molecular Raises USD15.7 Million in First Tranche of Series D Financing 54
Merck Global Health Acquires Physicians Interactive From Perseus 55
Cerveau Technologies Enters into Licensing Agreement with Merck 56
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 57
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 58
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 59
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 60
OpGen Enters into Research Agreement with Merck 61
Takeda Pharma Enters into Agreement with Koneksa Health 62
Merck Enters into Co-Development Agreement with Amoy Diagnostics 63
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 64
Merck to Enter into Co-Development Agreement with Biocartis 65
Daktari Diagnostics Enters into Agreement with Merck 66
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 67
Dako Enters into Agreement with Merck for Companion Diagnostic Test 68
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 69
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 70
Merck Enters Into Co-Development Agreement With Geisinger Health System 71
Ezose Sciences Enters Into Co-Development Agreement With Merck 72
F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck 73
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 74
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 75
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 77
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 78
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 79
OpGen Acquires AdvanDx 80
Physicians Interactive Acquires Tomorrow Networks 81
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 82
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 84
Merck & Co Inc, Key Competitors 85
Merck & Co Inc, Key Employees 86
Merck & Co Inc, Subsidiaries 88
Merck & Co Inc, Joint Venture 111